Medicines Co
Change company Symbol lookup
Select an option...
MDCO Medicines Co
FB Facebook Inc
SRPT Sarepta Therapeutics Inc
VYGR Voyager Therapeutics Inc
TRVB Tri-Valley Bank
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
POAGX PRIMECAP Odyssey Aggressive Growth Fund

Health Care : Pharmaceuticals | Small Cap BlendCompany profile

The Medicines Company is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery of medicines to the hospital marketplace around the world. It markets Angiomax (bivalirudin), Ionsys (fentanyl iontophoretic transdermal system), Minocin (minocycline) for injection and Orbactiv (oritavancin). It also has a pipeline of products in development, including Carbavance, inclisiran and MDCO-700. Carbavance is used for the treatment of hospitalized patients with gram-negative bacterial infections. Inclisiran is used for the treatment of hypercholesterolemia. MDCO-700 includes sedative-hypnotic, which is used to induce and maintain sedation for procedural care and general anesthesia for surgical care. In addition to these products and products in development, it has a portfolio of generic drugs.

Closing Price
Day's Change
-0.84 (-2.53%)
B/A Size
Day's High
Day's Low

10-day average volume:

Upcoming Events

MDCO's fiscal year ends in December
There are no upcoming events for MDCO

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
February 21, 2018Q4 2017 Earnings Release-$1.58-$1.72 to -$0.86-$1.75
October 25, 2017Q3 2017 Earnings Release-$0.42-$1.79 to -$1.02-$1.23
August 9, 2017Q2 2017 Earnings Release-$5.52-$5.12 to -$1.10$2.62
April 26, 2017Q1 2017 Earnings Release-$1.44-$1.71 to -$1.03-$1.34

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2018. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.